$16MSeries A, 12 June 2025
Funds will take its vascular patch toward first-in-human clinical trials.
- Amount
- $16M
- Stage
- Series A
- Announced
- 12 June 2025
- Lead
- Ship2B Ventures
- Other investors
- Clave Capital
- Use of funds
- Funds will take its vascular patch toward first-in-human clinical trials.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Aortyx raises €13.8M Venture tech.eu
Aortyx raises €13.8M Venture techfundingnews.com